• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Healthcare·6078.T
Share

Value HR Co.,Ltd. Stocks

¥ 1566Last Updated 18.09.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

¥ 267.97M

¥ 1566
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in Tokyo, Japan, in 2001, Value HR Co.,Ltd. specializes in providing a wide array of healthcare services. The company is primarily involved in the conceptualization, development, operation, and administration of its Value Cafeteria welfare support system. For businesses, Value HR offers consultancy on establishing health insurance associations, industrial health services, welfare programs, and acts as an agent for medical checkups. Additionally, it supports health insurance societies and health checkup facilities with administrative outsourcing, temporary staffing solutions, health management and data analytics assistance, probate services, and electronic application system implementation. The company further provides bespoke systems, including a web-based metabo countermeasure support system, a stress check system, and a medical expense itemization notification system.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.09.2026 09:00

Apple is developing a new type of device, according to Bloomberg. What is known about the gadget?

23.09.2026 07:30

In the U.S., a second IPO has been canceled in less than a week. Why is this a cause for concern?

23.09.2026 02:52

Anthropic has released a new, cost-effective AI model. How did the creator of ChatGPT respond?

23.09.2026 01:36

The Nasdaq closed at a record high for the second day in a row. Oil prices fell to a two-week low.

23.09.2026 00:34

Meta Has Created a "Killer Product": What Wall Street Is Saying About the New AI Assistant, Muse

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026